Switching to E-Cigarettes or Quitting Reduces Cardiac Risks After PCI

Written By :  Dr Riya Dave
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-11-28 15:15 GMT   |   Update On 2024-11-28 15:15 GMT
Advertisement

Researchers have found that patients with coronary artery disease (CAD) who had transitioned entirely to e-cigarettes or quit smoking altogether after percutaneous coronary intervention (PCI) had fewer major adverse cardiac events (MACE) compared to those who continued smoking combustible cigarettes. A recent study was conducted by Danbee Kang and colleagues which was published in the European Heart Journal.

Advertisement

Smoking is a major modifiable risk factor for cardiovascular disease, including coronary artery disease. Quitting smoking has been shown to improve the outcome, but how E-cigarettes serve as an alternative remains unclear. In this study, researchers examined whether switching to E-cigarettes has an impact on post-PCI outcomes, specifically on the risk of MACE.

Grouping from the Korean National Health Insurance database, 17,973 adult smokers (≥20 years) who underwent PCI and had completed health screens within 3 years before and after PCI. Participants were categorized into three groups:

  • Continued combustible cigarette users (49.8%, n=8,951).

  • Switchers to E-cigarettes (9.4%, n=1,694).

  • Subdivided into dual users and exclusive E-cigarette users.

  • Successful quitters (40.7%, n=7,328).

MACE incidence:

  • Continued combustible cigarette smokers: 17%.

  • E-cigarette switchers: 10%.

  • Successful quitters: 13.4%.

Adjusted hazard ratios for MACE:

  • E-cigarette switchers: 0.82 (95% CI: 0.69–0.98).

  • Successful quitters: 0.87 (95% CI: 0.79–0.96).

Dual users compared with exclusive E-cigarette users:

  • Exclusive e-cigarette use was strongly associated with reduced risk of MACE compared with dual use (HR: 0.71; 95% CI: 0.51-0.99).

Among smokers with PCI for CAD, smoking cessation and switching to e-cigarettes were both associated with less risk for MACE. These results show that smoking treatments which may improve the outcome in patients after PCI are necessary.

Reference:

Kang, D., Choi, K. H., Kim, H., Park, H., Heo, J., Park, T. K., Lee, J. M., Cho, J., Yang, J. H., Hahn, J.-Y., Choi, S.-H., Gwon, H.-C., & Song, Y. B. (2024). Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study. European Heart Journal. https://doi.org/10.1093/eurheartj/ehae705

Tags:    
Article Source : European Heart Journal

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News